Pfizer seeking emergency use of its COVID-19 vaccine in US
Associated Press
Pfizer said Friday it is asking U.S. regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic -- but not until after a long, hard winter.
The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.
Click the heart to favorite
Friday, November 20, 2020 - 11:03am
Tags
Campus News
In the Media
Inside Higher Ed
The Bellingham Herald
Associated Press